What question did this study set out to answer?

This research aims to explore how Mahuang Lianqiao Chixiaodou Decoction (MLCD) affects IgA nephropathy through specific signaling pathways.

January 24, 2026

Study of the Mechanism of Mahuang Lianqiao Chixiaodou Decoction against IgA Nephropathy Based on a Combined Strategy of Transcriptomics and Network Pharmacology Analysis.

View Full Paper

Ask AI

Bookmark

This research aims to explore how Mahuang Lianqiao Chixiaodou Decoction (MLCD) affects IgA nephropathy through specific signaling pathways.
Utilized transcriptomics to identify gene expressions associated with IgA nephropathy
Applied network pharmacology to analyze the interactions of MLCD components
Examined effects on the TLR9/MAPK/NF-κB signaling pathway in IgAN models
MLCD effectively reduces the inflammatory response in IgA nephropathy models
Significant improvement in kidney function observed
Regulation of the TLR9/MAPK/NF-κB signaling pathway confirmed as a key mechanism

Research reveals that Mahuang Lianqiao Chixiaodou Decoction improves kidney function in IgA nephropathy, highlighting its therapeutic potential.

MLCD can reduce the inflammatory response and improve kidney function in IgAN models by regulating the TLR9/MAPK/NF-κB signaling pathway.

No takes yet. Share an insight, caveat, or question.

Li et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Research reveals that Mahuang Lianqiao Chixiaodou Decoction improves kidney function in IgA nephropathy, highlighting its therapeutic potential.

MLCD can reduce the inflammatory response and improve kidney function in IgAN models by regulating the TLR9/MAPK/NF-κB signaling pathway.